Skip to main
TRNS
TRNS logo

Transcat (TRNS) Stock Forecast & Price Target

Transcat (TRNS) Analyst Ratings

Based on 3 analyst ratings
Buy
Strong Buy 67%
Buy 0%
Hold 33%
Sell 0%
Strong Sell 0%

Bulls say

Transcat Inc., a provider of calibration and laboratory instrument services, is positioned for growth with significant revenue contributions from its Service segment, which enhances its earnings visibility. The company is expected to benefit from expanding gross margins and is seen as an attractive investment, especially during any short-term market fluctuations. The belief in a warranted premium multiple reflects confidence in Transcat's potential as a profitable entity amidst increasing demand for its diverse portfolio of measurement and control instruments.

Bears say

Transcat Inc faces several fundamental risks that contribute to a negative outlook on its stock, including dilution risk associated with potential capital raises and significant customer concentration, which can lead to revenue instability. Additionally, the company is grappling with increased competition from web-based retailers in its distribution segment, posing a threat to market share and profitability. Furthermore, the small capitalization and lower liquidity of shares create heightened volatility, further complicating the investment landscape for Transcat.

Transcat (TRNS) has been analyzed by 3 analysts, with a consensus rating of Buy. 67% of analysts recommend a Strong Buy, 0% recommend Buy, 33% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of Transcat and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About Transcat (TRNS) Forecast

Analysts have given Transcat (TRNS) a Buy based on their latest research and market trends.

According to 3 analysts, Transcat (TRNS) has a Buy consensus rating as of Dec 16, 2025. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $102, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $102, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

Transcat (TRNS)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.